PharmaZell
GermanyWho owns PharmaZell?
PharmaZell is a German Pharma company, currently owned by Bridgepoint since 2020. It changed hands in 2020, when DPE Deutsche Private Equity and Maxburg Capital Partners sold.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Key facts
- ·Held by Bridgepoint since 2020 (6Y hold).
- ·Average hold across 3 realized cycles: 6 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Auctus Capital Partners sold PharmaZell to Ergon Capital Partners in 2011 after 5 years.
DPE Deutsche Private Equity sold PharmaZell to Bridgepoint in 2020 after 6 years.
Maxburg Capital Partners sold PharmaZell to Bridgepoint in 2020 after 6 years.
More from Europe VI (BE VI)
Other portfolio companies in the same fund.
Netherlands
Ireland
Switzerland
France
USMore PE-backed in Pharma
Comparable pharma deals from other GPs.
SpainQuestions
Who owns PharmaZell?
PharmaZell is currently owned by Bridgepoint, through Europe VI (BE VI), since 2020.
When did Bridgepoint acquire PharmaZell?
Bridgepoint acquired PharmaZell in 2020.
Who did PharmaZell sell to?
DPE Deutsche Private Equity and Maxburg Capital Partners sold PharmaZell to Bridgepoint in 2020 (Secondary). Auctus Capital Partners sold PharmaZell to Ergon Capital Partners in 2011 (Secondary).
Who has owned PharmaZell over time?
PharmaZell has been through 4 private-equity ownership periods: Auctus Capital Partners · via Auctus I (Evergreen) · 2006–2011 · sold to Ergon Capital Partners · (Secondary); DPE Deutsche Private Equity · via DPE Fund II · 2014–2020 · sold to Bridgepoint · (Secondary); Maxburg Capital Partners · via Maxburg Beteiligungen · 2014–2020 · sold to Bridgepoint · (Secondary); Bridgepoint · via Europe VI (BE VI) · since 2020.